PDS Biotechnology Corporation
PDSB
$1.61
-$0.01-0.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.68% | -16.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.71% | -27.69% | |||
| Operating Income | -23.71% | 27.69% | |||
| Income Before Tax | -21.46% | 25.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.75% | 25.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.75% | 25.86% | |||
| EBIT | -23.71% | 27.69% | |||
| EBITDA | -23.76% | 27.73% | |||
| EPS Basic | 1.23% | 27.21% | |||
| Normalized Basic EPS | -12.37% | 27.18% | |||
| EPS Diluted | 1.23% | 27.21% | |||
| Normalized Diluted EPS | -12.37% | 27.18% | |||
| Average Basic Shares Outstanding | 8.09% | 1.85% | |||
| Average Diluted Shares Outstanding | 8.09% | 1.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||